Stock Price Quote

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE981.25-34.75 (-3.42 %)
PREV CLOSE ( ) 1016.00
OPEN PRICE ( ) 1010.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 57220
TODAY'S LOW / HIGH ( )972.60 1018.85
52 WK LOW / HIGH ( )505 1121.85
NSE979.60-36.95 (-3.63 %)
PREV CLOSE( ) 1016.55
OPEN PRICE ( ) 1009.00
BID PRICE (QTY) 979.60 (506)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2899900
TODAY'S LOW / HIGH( ) 971.25 1019.00
52 WK LOW / HIGH ( )504.75 1122.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 6640 2323

Email info@lupinworld.com

Website www.lupinworld.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

23Sep Reliance Industries, Sun Pharma and IO
Global investment firm KKR is planning to invest Rs 5,550 crore into Rel..
23Sep Lupin informs about allotment of equit
Lupin has informed that the Allotment Committee of Directors at its meet..
22Sep Lupin launches Divalproex Sodium ER Ta
Lupin has launched Divalproex Sodium Extended-Release (ER) Tablets USP,..
03Sep Lupin, Ashok Leyland and TVS Motor to
Lupin has launched Leflunomide Tablets USP, 10 mg and 20 mg, having rece..
03Sep Lupin gains on launching Leflunomide T
Lupin is currently trading at Rs. 965.15, up by 1.20 points or 0.12% fro..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit3635.87275.5
Gross Profit 4954.9 10522.5
Operating Profit 6293.123828
Net Sales 26950.8110256.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE)
peergroup  2831.10 (3.22%)
M.Cap ( in Cr)32793.09
Advanced Enzyme (BSE)
peergroup  272.80 (19.99%)
M.Cap ( in Cr)3046.59
Hester Biosciences (BSE)
peergroup  1747.00 (1.13%)
M.Cap ( in Cr)1484.41
Alembic Pharma (BSE)
peergroup  934.35 (2.04%)
M.Cap ( in Cr)18201.75
Natco Pharma (BSE)
peergroup  860.20 (1.10%)
M.Cap ( in Cr)15421.16

Shareholding Pattern

FI/BANKS/INSURANCE 6.56%
PROMOTERS 46.92%
NON-INSTITUTION 12.91%
MUTUAL FUNDS/UTI 11.94%
GOVERNMENT 0.29%
FII 0%

About Lupin Ltd.

Lupin Ltd. was incorporated in the year 1983. Its today's share price is 1016. Its current market capitalisation stands at Rs 44385.83 Cr. In the latest quarter, company has reported Gross Sales of Rs. 317176.2 Cr and Total Income of Rs.173203.2 Cr. The company's management includes Christine Mundkur, Jean-Luc Belingard, Dileep C Choksi, K U Mada, Richard Zahn, R A Shah, Ramesh Swaminathan, Nilesh Gupta, Vinita Gupta, Kamal K Sharma, Manju D Gupta.

It is listed on the BSE with a BSE Code of 500257 , NSE with an NSE Symbol of LUPIN and ISIN of INE326A01037. It's Registered office is at Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East)Mumbai-400055, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arora & Arora, BSR & Co LLP, Deloitte Haskins & Sells, Deloitte Haskins & Sells LLP, Deloittee Haskins & Sells, SS Kapoor & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)